Literature DB >> 6363437

Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients.

R R Revers, O G Kolterman, J A Scarlett, R S Gray, J M Olefsky.   

Abstract

Although type I diabetic patients are clearly insulin deficient, it is unclear whether they have normal in vivo sensitivity to insulin. Recent studies which suggested that insulin resistance is a common feature of insulin-dependent diabetics have not taken into account their degree of metabolic control or the presence of circulating antibodies. In the present study, we performed multiple euglycemic glucose clamp studies to construct insulin dose-response curves in 5 well controlled and 5 poorly controlled type I diabetic patients and 21 age-matched normal subjects. Each study was performed on a separate day at insulin infusion rates of 15, 40, 120, 240, or 1200 mU/M2 X min. During the 40 and 120 mU/M2 X min infusions, steady state insulin levels of 96 +/- 8 (+/- SE) and 285 +/- 27 microU/ml respectively, were achieved within 25 min in normal subjects. In contrast, diabetic subjects did not achieve steady state insulin levels (62 +/- 8 and 212 +/- 16 microU/ml) until 90 min of infusion, and insulin antibodies were detectable in the serum of all these patients. The dose-response curve for insulin stimulation of glucose disposal in well controlled diabetic subjects was comparable to that in normal subjects, with half-maximally effective insulin levels of 84 microU/ml in the diabetic patients compared to 70 microU/ml in normal subjects and virtually identical maximal rates of glucose disposal (433 +/- 11 vs. 411 +/- 17 mg/M2 X min in controls). In contrast, the dose-response curve for poorly controlled diabetic subjects was significantly right-shifted (half-maximally effective insulin level, 112 microU/ml), with marked reduction in the maximal glucose disposal rate (324 +/- 25 vs. 411 +/- 17 mg/M2 X min in normal subjects). Basal hepatic glucose output was increased in both poorly controlled and well controlled type I diabetic patients (132 +/- 7 and 101 +/- 16 mg/M2 X min, respectively) compared to normal subjects (76 +/- 7 mg/M2 X min). However, during each insulin infusion, hepatic glucose output was virtually 100% suppressed in all 3 groups.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363437     DOI: 10.1210/jcem-58-2-353

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes.

Authors:  O Hother-Nielsen; O Schmitz; J Bak; H Beck-Nielsen
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

2.  Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus.

Authors:  G W Cline; I Magnusson; D L Rothman; K F Petersen; D Laurent; G I Shulman
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

3.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.

Authors:  A D Baron; J S Zhu; J H Zhu; H Weldon; L Maianu; W T Garvey
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.

Authors:  Kazuaki Ohtsubo; Mark Z Chen; Jerrold M Olefsky; Jamey D Marth
Journal:  Nat Med       Date:  2011-08-14       Impact factor: 53.440

5.  Characterization of insulin resistance in type I diabetes.

Authors:  W Kerner; I Navascués; T von Schrenck; R Fussgänger; P Arias; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1985-06-18

6.  Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used.

Authors:  P M Bell; R G Firth; R A Rizza
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus.

Authors:  F I Martin; J L Hopper
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

8.  Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.

Authors:  R S Gray; P Cowan; U di Mario; R A Elton; B F Clarke; L J Duncan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

9.  Effect of nicotinic acid-induced insulin resistance on pancreatic B cell function in normal and streptozocin-treated baboons.

Authors:  D K McCulloch; S E Kahn; M W Schwartz; D J Koerker; J P Palmer
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

10.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.

Authors:  L Rossetti; D Smith; G I Shulman; D Papachristou; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.